Audited Results of Q-Line Biotech Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	341.16	313.07	203.68	183.09	278.38
Manufacturing Expenses	0	0	0	0	0
Personnel Expenses	38.78	29.85	23.98	22.91	24.10
Selling Expenses	0	0	0	0.03	0.03
Administrative Expenses	69.10	65.44	35.13	29.70	37.01
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	242.04	241.54	160.33	146.63	211.74
Operating Profit	99.12	71.54	43.34	36.46	66.64
Other Recurring Income	5.73	8.83	2.83	2.38	1.37
Adjusted PBDIT	104.85	80.37	46.17	38.84	68.01
Financial Expenses	18.88	14.91	7.10	4.48	3
Depreciation	10.78	6.93	4.22	1.81	1.30
Other Write offs	0	0	0	0	0
Adjusted PBT	75.19	58.52	34.85	32.55	63.71
Tax Charges	17.27	19.15	8.99	8.38	16.20
Adjusted PAT	57.93	39.38	25.85	24.17	47.51
Non Recurring Items	-0.98	13.74	0	0	0
Other Non Cash adjustments	0	-5.73	0	0	0
Reported Net Profit	56.95	47.40	25.85	24.17	47.51
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Retained Earnings	56.95	47.40	141.36	116.75	93.25

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article